Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-31

FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Original Application (Advagen Pharma Limited)

View source ↗

Summary

FDA approved Cyclobenzaprine hydrochloride as an original application generic product manufactured by Advagen Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOBENZAPRINE HYDROCHLORIDE (Cyclobenzaprine hydrochloride)

Snippet

ORIG AP for CYCLOBENZAPRINE HYDROCHLORIDE (CYCLOBENZAPRINE HYDROCHLORIDE)